Dermot P. B. McGovern, MD, PhD, MRCP (UK)
Director, Translational Medicine, Inflammatory Bowel Disease Center and Immunobiology Research Institute
Dermot McGovern, MD, PhD is Director of Translational Medicine for the Inflammatory Bowel Disease Center and Immunobiology Research Institute at Cedars-Sinai Medical Center. Dr. McGovern is also Associate Professor of Medicine at University of California, Los Angeles David Geffen School of Medicine.
Dr. McGovern's main clinical and research interests are in understanding the effect of genetic variants on susceptibility, natural history and response to therapy of the inflammatory bowel diseases, ulcerative colitis and Crohn's disease.
Dr. McGovern has authored or co-authored numerous articles for peer-reviewed publications, including articles in Nature Genetics, The American Journal of Human Genetics, Human Molecular Genetics, The Lancet, GUT and Gastroenterology. He is a member of the editorial board of The IBD Journal.
Dr. McGovern earned his medical degree from St. Mary's Hospital Medical School at the University of London and is a Member of the Royal College of Physicians of London. He completed his fellowship at the University of Oxford, UK where he also earned a doctorate in IBD Genetics.
